-
Researchers develop a probe that helps detect cancers cells with almost 100% accuracy
A probe that was first developed by researchers in Canada in 2015 has since been perfected by the team
-
Launching The Everest Centre for research into childhood brain tumours
A groundbreaking international centre for research into childhood brain tumours will be launched today (June 27) in London
-
Scientists have discovered that a lack of ‘editing’ could be driving the most aggressive brain tumours
A new study from the CSIR-Institute of Genomics and Integrative Biology in India examined the mechanism of gene expression within brain tumours and found a lack of microRNA editing
-
Scientists have discovered a protein that could potentially predict glioblastoma outcomes
Scientists from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that the protein BCL6 could potentially be used as a marker to predict the clinical outcome of patients with glioblastoma
-
General Election 2017 result: No overall majority as Labour make unexpected gains
After seven weeks of relentless political campaigning across the UK, voters finally had their say at polling booths on Thursday, as a shock ‘hung parliament’ result emerged
-
Researchers from the University of Ohio have found changes in blood that are detectable five years before the diagnosis of brain cancer
A study conducted by Judith Schwartzbaum from the University of Ohio has found that changes in the immune systems appear to signal brain cancer 5 years before symptoms arise
-
Scientists discover enzyme that supports brain tumour growth
Researchers from the University of Texas MD Anderson have discovered an enzyme that helps brain tumours grow in nutrient-starved environments
-
Proud to be part of the launch of Less Survivable Cancers Taskforce
Yesterday saw the launch of the Less Survivable Cancers Taskforce to an audience of members of the Scottish Parliament in Holyrood, Edinburgh
-
Could the Zika virus be used to treat glioblastomas?
The University of Cambridge is to begins trials using the Zika virus on glioblastoma, the most common and aggressive form of brain tumour. Glioblastomas affect 2,200 people in the UK each year
-
New insight into medulloblastoma
The most common type of malignant childhood brain cancer has been identified as seven separate conditions each needing a different treatment, new research has revealed.
-
Announcing our new patient-led data bank initiative
We are launching a global, patient-led data bank, which will allow patients to unite in sharing their data, helping them to make better informed decisions about their own treatment plans, as well as helping vital research that could bring us closer to finding a cure.
-
We are co-funding Marie Curie’s call to address gaps in palliative and end of life care research
The terminal illness charity is looking for applications that address its key research priorities identified by carers, health and social care professionals and people with terminal illness, and particularly, those areas that have until now received the least attention
-
University fashion show raises £28,000
St Andrew’s Fashion Show (FS) has raised over £28,000 for The Brain Tumour Charity in a bid to fund research in to vital treatments to tackle the disease.
-
Benefit cut equals further hurt for the bereaved
Why a decision to cut benefits paid to bereaved parents is not in the interests of affected families.
-
UK research into the use of cannabidiol to treat brain tumours
Researchers from the Nottingham University’s children’s brain tumour centre are now looking into the effects of cannabidiol (CBD), the non-psychoactive ingredient in marijuana
-
Team Ipreo take on Tough Mudder
An energetic team from global financial services technology company Ipreo will soon be taking on the gruelling Tough Mudder in support of The Brain Tumour Charity.
-
United in the call for brain tumour one-year survival targets to be met
The Brain Tumour Charity CEO, Sarah Lindsell, has co-signed a letter to NHS organisations urging them to meet their one-year survival targets for the early diagnosis of brain tumours.
-
As a snap general election is called, our battle continues
While Theresa May admits division in Westminster, our Chief Executive Sarah Lindsell says we must stand together stronger than ever to defeat brain tumours.
-
A neurosurgeon’s view
Trainee neurosurgeon at University Hospital Coventry and Warwickshire, Yasir Chowdhury, shines a light on day-to-day life in one of the most complex and dangerous areas of surgery and shares his hopes for finding a cure for brain tumours
-
How we’re fighting for people affected by brain tumours
From establishing a new cancer taskforce to ensuring benefits reviews take brain tumour patients into account, read our roundup of key activities from the past few weeks.
-
Immunotherapy drug shows lack of promise in Phase 3 clinical trial for glioblastoma patients
Last week Bristol-Myers Squibb announced the initial results from their Phase 3 clinical trial that was assessing the effectiveness and safety of the immunotherapy drug Nivolumab in patients with recurrent glioblastoma.
-
A new, non-disruptive brain surgery technology is now being used in London
BrainPath is a surgical technique that uses the brain’s own tissue folds to tract a path to the tumour site. It is designed to be minimally invasive.
-
We know mental health can affect those living with a brain tumour, but are we doing enough?
Ally Rooney posts an open letter to doctors, nurses, and allied health professionals who care for people with a brain tumour.
-
How has DevoManc affected The Brain Tumour Charity?
Last year, Greater Manchester became the first English region to gain control of health spending. Read our view on the impact this has had on charities.